Current status and hotspot research on the prevention and treatment of cancer-related anemia with traditional Chinese medicine

HOU Li

doi:10.16025/j.1674-1307.2025.07.001

您当前的位置：

首页 >

文章列表页 >

Current status and hotspot research on the prevention and treatment of cancer-related anemia with traditional Chinese medicine

更新时间：2025-09-11

- Current status and hotspot research on the prevention and treatment of cancer-related anemia with traditional Chinese medicine
- Beijing Journal of Traditional Chinese Medicine Vol. 44, Issue 7, Pages: 816-819(2025)
- 作者机构：
  
  北京中医药大学东直门医院血液肿瘤科，北京 100700
- 作者简介：
- 基金信息：
- DOI：10.16025/j.1674-1307.2025.07.001
  CLC：
- Received：23 April 2025，
  
  Published：25 July 2025
- 稿件说明：
移动端阅览
侯丽.中医药防治恶性肿瘤相关性贫血现状与热点研究述评［J］.北京中医药，2025，44（7）：816-819.

HOU Li.Current status and hotspot research on the prevention and treatment of cancer-related anemia with traditional Chinese medicine[J]. Beijing Journal of Traditional Chinese Medicine,2025,44(07):816-819.
侯丽.中医药防治恶性肿瘤相关性贫血现状与热点研究述评［J］.北京中医药，2025，44（7）：816-819. DOI： 10.16025/j.1674-1307.2025.07.001.

HOU Li.Current status and hotspot research on the prevention and treatment of cancer-related anemia with traditional Chinese medicine[J]. Beijing Journal of Traditional Chinese Medicine,2025,44(07):816-819. DOI： 10.16025/j.1674-1307.2025.07.001.

摘要

肿瘤相关性贫血（cancer-related anemia，CRA）是恶性肿瘤发生进展和治疗过程中常见并发症，严重影响患者治疗效果及生活质量，是患者生存和预后的独立危险因素。中医药防治CRA疗效明确，且在CRA防、治、康全程管理中具有独特优势。

Abstract

Cancer-related anemia （CRA） is a common complication during the occurrence， progression， and treatment of malignant tumors， seriously affecting therapeutic efficacy and quality of life， and serving as an independent risk factor for patient survival and prognosis. Traditional Chinese medicine （TCM） has demonstrated definite efficacy in the prevention and treatment of CRA， with unique advantages in the comprehensive management of prevention， treatment， and rehabilitation.

关键词

Keywords

references

DE PUTTER R , GEBOES K , DE MAN M , et al . Treatment of anemia in patients with solid tumors receiving chemotherapy in palliative setting:usual practice versus guidelines [J ] . Acta Clin Belg , 2018 , 73 ( 4 ): 251 - 256 .

宋正波 , 陆舜 , 冯继锋 , 等 . 中国肿瘤相关性贫血发生率及治疗现状的流行病学调查研究 [J ] . 中国肿瘤 , 2019 , 28 ( 9 ): 718 - 722 .

马军 , 王杰军 , 张力 , 等 . 肿瘤相关性贫血临床实践指南（2015—2016版） [J ] . 中国实用内科杂志 , 2016 , 36 ( 1 ): 1 - 21 .

蓝海 , 侯丽 , 郎海燕 , 等 . 常见血液病的中医分类与命名 [J ] . 中医杂志 , 2019 , 60 ( 9 ): 750 - 753,778 .

侯丽 , 董青 , 田劭丹 , 等 . 肿瘤相关性贫血中医药防治专家共识 [J ] . 北京中医药 , 2021 , 40 ( 1 ): 48 - 52 .

李欣 , 薛娜 , 丁彤晶 , 等 . 王笑民妙用柴胡桂枝汤治疗肿瘤的思路及经验 [J ] . 北京中医药 , 2025 , 44 ( 3 ): 348 - 352 .

黄孝玲 , 张雅月 , 胡凯 , 等 . 基于“壮火”理论辨治嵌合抗原受体T细胞治疗相关细胞因子释放综合征的经验 [J ] . 北京中医药 , 2024 , 43 ( 4 ): 393 - 396 .

张保根 , 杨澍 , 陈文 . 肿瘤相关性贫血中西医治疗进展 [J ] . 中国中医药现代远程教育 , 2023 , 21 ( 23 ): 204 - 206 .

娄彦妮 , 陈信义 , 侯丽 , 等 . 癌性贫血的中医证候与用药规律分析 [J ] . 中华中医药杂志 , 2015 , 30 ( 6 ): 2066 - 2069 .

吴溪洋 , 高宏 , 唐广义 . 肿瘤相关性贫血的证型分布和用药规律 [J ] . 江西中医药 , 2019 , 50 ( 4 ): 50 - 52 .

张华征 , 邢向荣 , 张宁苏 . 大肠癌合并贫血相关因素分析与中医证型分布的临床研究 [J ] . 实用中医内科杂志 , 2020 , 34 ( 5 ): 127 - 130 .

LUDWIG H , VAN BELLE S , BARRETT-LEE P , et al . The European Cancer Anaemia Survey(ECAS):a large, multinational, prospective survey defining the prevalence,incidence, and treatment of anaemia in cancer patients [J ] . Eur J Cancer , 2004 , 40 ( 15 ): 2293 - 2306 .

侯丽 , 姜苗 , 陈信义 , 等 . 晚期非小细胞肺癌围化疗期中药参与治疗回顾性临床研究 [J ] . 中国中医基础医学杂志 , 2006 , 12 ( 5 ): 359 - 360,363 .

刘铸 , 许晶 , 殷玉琨 , 等 . 365例接受三线及以上抗肿瘤治疗的晚期肺癌合并贫血患者的临床特征分析 [J ] . 北京中医药 , 2025 , 44 ( 1 ): 47 - 52 .

DANG Z , LIU X , WANG X , et al . Comparative effectiveness and safety of traditional Chinese medicine supporting Qi and enriching blood for cancer related anemia in patients not receiving chemoradiotherapy: a meta-analysis and systematic review [J ] . Drug Des Devel Ther , 2018 , 13 : 221 - 230 .

XU J , WU K , LI X , et al . Effectiveness and safety of seven oral Chinese patent medicines as adjuvant therapy for cancer-related anemia:a systematic review and network meta-analysis of randomized controlled trials [J ] . J Tradit Chin Med Sci , 2023 , 10 ( 2 ): 150 - 160 .

王历刚 , 杨柳 , 陈柳茵 , 等 . 当归补血汤治疗肿瘤相关性贫血的Meta分析和GRADE评价 [J ] . 山西中医药大学学报 , 2023 , 24 ( 1 ): 1 - 9 .

黄敏娜 , 贾英杰 , 陈军 , 等 . 中医药治疗肿瘤相关性贫血疗效的Meta分析 [J ] . 中国中西医结合外科杂志 , 2017 , 23 ( 4 ): 343 - 348 .

许晶 , 董石 , 董青 , 等 . 中医药防治肿瘤相关性贫血的优势与特色 [J ] . 北京中医药大学学报 , 2022 , 45 ( 11 ): 1089 - 1094 .

李幸蔚 , 周吉成 . 肿瘤相关性贫血的研究进展 [J ] . 临床血液学杂志 , 2024 , 37 ( 10 ): 750 - 754 .

胡梦云 , 付烊 , 莫天栩 , 等 . 茯贞膏对脾肾阳虚型肿瘤相关性贫血大鼠的治疗作用研究 [J ] . 中医临床研究 , 2019 , 11 ( 21 ): 8 - 11 .

张硕 , 姜晓燕 , 沈水杰 , 等 . 基于HIF-1α/PD-L1通路探讨补血生髓方对肿瘤相关性贫血小鼠的改善作用 [J ] . 四川中医 , 2024 , 42 ( 3 ): 79 - 83 .

张硕 , 姜晓燕 , 符映均 , 等 . 基于斑马鱼模型的补血生髓方对肿瘤相关性贫血和免疫功能低下的保护作用 [J ] . 世界科学技术-中医药现代化 , 2024 , 26 ( 5 ): 1320 - 1327 .

SHI XQ , ZHU ZH , YUE SJ , et al . Studies on blood enrichment and anti-tumor effects of combined Danggui Buxue Decoction,Fe and rhEPO based on colon cancer-related anemia model and gut microbiota modulation [J ] . Chin J Nat Med , 2021 , 19 ( 6 ): 422 - 431 .

中国抗癌协会肿瘤临床化疗专业委员会 , 中国抗癌协会肿瘤支持治疗专业委员会 . 中国肿瘤相关贫血诊治专家共识(2023版) [J ] . 中华肿瘤杂志 , 2023 , 45 ( 12 ): 1032 - 1040 .

中国临床肿瘤学会指南工作委员会 . 中国临床肿瘤学会(CSCO)肿瘤相关性贫血临床实践指南2024 [M ] . 北京 : 人民卫生出版社 , 2024 : 2 - 68 .

GLASPY J , GABRAIL NY , LOCANTORE-FORD P , et al . Open-label,Phase 2 study of roxadustat for the treatment of anemia in patients receiving chemotherapy for non-myeloid malignancies [J ] . Am J Hematol , 2023 , 98 ( 5 ): 703 - 711 .

LU S , WU J , JIANG J , et al . LBA96 Roxadustat for chemotherapy-induced anemia in patients with non-myeloid malignancies:a randomized, open-label,active-controlled,phase Ⅲ study [J ] . Annals of Oncology , 2023 , 34 ( 2 ): 1335 - 1336 .

Views

下载量

CSCD

Alert me when the article has been cited

提交

Tools

Publicity Resources

Clinical and basic research on differentiation and treatment of ankylosing spondylitis in traditional Chinese medicine: a review

A case of recurrent implantation failure after six IVF-ET cycles treated with the method of nourishing the kidney and soothing the liver

Clinical efficacy of Mafu Yishen Decoction in treating intermediate-and high-risk membranous nephropathy

Traditional Chinese medicine treatment of idiopathic pulmonary fibrosis based on NLRP3 inflammasome: a review

Clinical characteristic analysis of 365 advanced lung cancer patients complicated with anemia receiving third-line or higher anti-cancer therapy

Related Author

LIU Hongxiao

GONG Yifan

WU Qunli

LI Yaoyang

ZHANG Duoduo

JIA Yifan

HUANG Shuxian

RUI Hongliang

Related Institution

Department of Rheumatology， Guang'anmen Hospital， China Academy of Chinese Medical Sciences

Department of Obstetrics and Gynecology， National Clinical Research Center for Obstetrics and Gynecology Diseases， Peking Union Medical College Hospital， Chinese Academy of Medical Sciences & Peking Union Medical College

Department of Traditional Chinese Medicine， Peking Union Medical College Hospital， Chinese Academy of Medical Sciences & Peking Union Medical College

Nephrology and Rheumatism Immune Diagnosis and Treatment Center， Beijing Hospital of Traditional Chinese Medicine Affiliated to Capital Medical University

Macau University of Science and Technology，State Key Laboratory of Quality Research in Chinese Medicine， Macau

⁰